Vanderbilt-ingram Cancer Center
Clinical trials sponsored by Vanderbilt-ingram Cancer Center, explained in plain language.
-
New scan aims to spot hidden cancer, reduce unneeded biopsies
Diagnosis Not yet recruitingThis early-stage study is testing a new radioactive imaging agent called [18F]NOTA-ABY030. The goal is to see if it is safe and if it can help doctors more clearly see head and neck cancer on a PET/CT scan, especially when standard scans show unclear spots. Researchers hope this …
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC
-
New scan aims to see cancer more clearly during treatment
Knowledge-focused Not yet recruitingThis study is testing a new imaging tracer called [68Ga]Ga-ABY-025 to see if it can help doctors better identify and visualize tumors in patients receiving standard HER2-targeted cancer therapy. It will involve about 30 adults with advanced HER2-positive cancers who are undergoin…
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC